
Easier to Prescribe Opioids Than Buprenorphine – Experts Lament Patient Barriers to Medication-Assisted Treatment
A panel of experts recently appeared before a Medicaid and

A panel of experts recently appeared before a Medicaid and

If you’re reading this post, you likely already know the

The public will have the opportunity to make comments on

Health and Human Services Secretary Alex Azar announced this November

An often dismissed option in the struggle to address opioid

AZZLY® partner DrFirst announced recently that their Electronic Prescribing of

As the opioid epidemic in the United States continues to

Update: On Wednesday, October 24, 2018, President Trump officially signed

AZZLY® is joining the National Association of Addiction Treatment Providers

On August 9th, Facebook announced a new policy requiring addiction
Medication-assisted therapy (MAT) has become a critical tool in addressing the opioid epidemic, but barriers exist that make it easier for healthcare providers to prescribe opioids rather than buprenorphine. Experts in the field have expressed frustration at the patient barriers that prevent individuals with opioid use disorder from accessing this life-saving treatment. Addressing these barriers, such as limited access to MAT providers and stigma associated with addiction, is essential in expanding the reach of effective treatment options.
The opioid crisis has been described as the worst public health crisis since AIDS, underscoring the urgent need for improved access to treatment for individuals struggling with opioid use disorder. Submitting comments on the Pain Management Best Practices Report to Congress is one way for the public to advocate for better policies and support for MAT programs. By increasing awareness and advocating for change, we can work towards reducing the devastating impact of opioids on individuals, families, and communities.
Medication-assisted therapy (MAT) has become a critical tool in addressing the opioid epidemic, but barriers exist that make it easier for healthcare providers to prescribe opioids rather than buprenorphine. Experts in the field have expressed frustration at the patient barriers that prevent individuals with opioid use disorder from accessing this life-saving treatment. Addressing these barriers, such as limited access to MAT providers and stigma associated with addiction, is essential in expanding the reach of effective treatment options.
The opioid crisis has been described as the worst public health crisis since AIDS, underscoring the urgent need for improved access to treatment for individuals struggling with opioid use disorder. Submitting comments on the Pain Management Best Practices Report to Congress is one way for the public to advocate for better policies and support for MAT programs. By increasing awareness and advocating for change, we can work towards reducing the devastating impact of opioids on individuals, families, and communities.